Cystic fibrosis screening: Difference between revisions
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Newborn screening identified most of the children with cystic fibrosis before the symptoms develop. | Newborn screening identified most of the children with cystic fibrosis before the symptoms develop. It offers this opportunity for early diagnosis and improved outcomes. | ||
==Screening== | ==Screening== | ||
In almost all of the Western countries, newborn screening for cystic fibrosis (CF NBS) has been introduced that identified most of the children with cystic fibrosis before the symptoms develop. It offers this opportunity for early diagnosis and improved outcomes in patients with cystic fibrosis.<ref name="pmid26366807">{{cite journal |vauthors=Gonska T, Ratjen F |title=Newborn screening for cystic fibrosis |journal=Expert Rev Respir Med |volume=9 |issue=5 |pages=619–31 |date=October 2015 |pmid=26366807 |doi=10.1586/17476348.2015.1085804 |url=}}</ref><ref name="pmid20521170">{{cite journal |vauthors=Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM |title=Cystic fibrosis newborn screening: using experience to optimize the screening algorithm |journal=J. Inherit. Metab. Dis. |volume=33 |issue=Suppl 2 |pages=S255–61 |date=October 2010 |pmid=20521170 |doi=10.1007/s10545-010-9117-3 |url=}}</ref> | In almost all of the Western countries, newborn screening for cystic fibrosis (CF NBS) has been introduced that identified most of the children with cystic fibrosis before the symptoms develop. It offers this opportunity for early diagnosis and improved outcomes in patients with cystic fibrosis.<ref name="pmid26366807">{{cite journal |vauthors=Gonska T, Ratjen F |title=Newborn screening for cystic fibrosis |journal=Expert Rev Respir Med |volume=9 |issue=5 |pages=619–31 |date=October 2015 |pmid=26366807 |doi=10.1586/17476348.2015.1085804 |url=}}</ref><ref name="pmid20521170">{{cite journal |vauthors=Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM |title=Cystic fibrosis newborn screening: using experience to optimize the screening algorithm |journal=J. Inherit. Metab. Dis. |volume=33 |issue=Suppl 2 |pages=S255–61 |date=October 2010 |pmid=20521170 |doi=10.1007/s10545-010-9117-3 |url=}}</ref> | ||
Revision as of 17:48, 23 February 2018
|
Cystic fibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cystic fibrosis screening On the Web |
|
American Roentgen Ray Society Images of Cystic fibrosis screening |
|
Risk calculators and risk factors for Cystic fibrosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Newborn screening identified most of the children with cystic fibrosis before the symptoms develop. It offers this opportunity for early diagnosis and improved outcomes.
Screening
In almost all of the Western countries, newborn screening for cystic fibrosis (CF NBS) has been introduced that identified most of the children with cystic fibrosis before the symptoms develop. It offers this opportunity for early diagnosis and improved outcomes in patients with cystic fibrosis.[1][2]
References
- ↑ Gonska T, Ratjen F (October 2015). "Newborn screening for cystic fibrosis". Expert Rev Respir Med. 9 (5): 619–31. doi:10.1586/17476348.2015.1085804. PMID 26366807.
- ↑ Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM (October 2010). "Cystic fibrosis newborn screening: using experience to optimize the screening algorithm". J. Inherit. Metab. Dis. 33 (Suppl 2): S255–61. doi:10.1007/s10545-010-9117-3. PMID 20521170.